SSSaurin R. Sutaria

Saurin R. Sutaria

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saurin R. Sutaria has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Aruni Bhatnagar

    Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, 302 E Muhammad Ali Blvd, Louisville, KY, 40202, USA; Department of Medicine, School of Medicine, University of Louisville, 550 S. Jackson St, Louisville, KY, 40202, USA

    3 shared publications
  • Michael H. Nantz

    Department of Chemistry, University of Louisville, Louisville, USA

    3 shared publications
  • Daniel J. Conklin

    Christina Lee Brown Envirome Institute, University of Louisville, USA; Superfund Research Center, University of Louisville, USA; American Heart Association-Tobacco Regulation and Addiction Center, University of Louisville, USA; Division of Environmental Medicine, Department of Medicine, University of Louisville, Louisville, KY 40202, USA

    2 shared publications
  • Jin Y. Chen

    Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, 302 E. Muhammad Ali Blvd., Louisville, KY 40202, United States; Superfund Research Center, University of Louisville, 302 E. Muhammad Ali Blvd., Louisville, KY 40202, United States; Division of Environmental Medicine, Department of Medicine, School of Medicine, 550 South Jackson Street, University of Louisville, Louisville, KY 40202, United States

    2 shared publications
  • Pawel Lorkiewicz

    University of Louisville

    2 shared publications
  • Rachel J. Keith

    Christina Lee Brown Envirome Institute, School of Medicine, University of Louisville, Louisville, KY 40202, USA

    2 shared publications

Latest Publications

  • Open Access

    Simultaneous profiling of mercapturic acids, glucuronic acids, and sulfates in human urine

    by Jin Y. Chen, Saurin R. Sutaria, Zhengzhi Xie, Manjiri Kulkarni, Rachel J. Keith, Aruni Bhatnagar, Clara G. Sears, Pawel Lorkiewicz, Sanjay Srivastava


  • Evaluation of urinary limonene metabolites as biomarkers of exposure to greenness

    by Zhengzhi Xie, Saurin R. Sutaria, Jin Y. Chen, Hong Gao, Daniel J. Conklin, Rachel J. Keith, Sanjay Srivastava, Pawel Lorkiewicz, Aruni Bhatnagar


  • Open Access

    A feasibility study on exhaled breath analysis using UV spectroscopy to detect COVID-19

    by Saurin R Sutaria, James D Morris, Zhenzhen Xie, Elizabeth A Cooke, Shavonne M Silvers, Grace A Long, Dawn Balcom, Subathra Marimuthu, Leslie W Parrish, Holly Aliesky, et al.

    A 23-subject feasibility study is reported to assess how UV absorbance measurements on exhaled breath samples collected from silicon microreactors can be used to detect COVID-19. The silicon microreactor technology chemoselectively preconcentrates exhaled carbonyl volatile organic compounds and subsequent methanol elution provides samples for analysis. The underlying scientific rationale that viral infection will induce an increase in exhaled carbonyls appears to be supported by the results of the feasibility study. The data indicate statistically significant differences in measured UV absorbance values between healthy and symptomatic COVID-19 positive subjects in the wavelength range from 235 nm to 305 nm. Factors such as subject age were noted as potential confounding variables.


  • Open Access

    Lipid Peroxidation Produces a Diverse Mixture of Saturated and Unsaturated Aldehydes in Exhaled Breath That Can Serve as Biomarkers of Lung Cancer—A Review

    by Saurin R. Sutaria, Sadakatali S. Gori, James D. Morris, Zhenzhen Xie, Xiao-An Fu, Michael H. Nantz

    The peroxidation of unsaturated fatty acids is a widely recognized metabolic process that creates a complex mixture of volatile organic compounds including aldehydes. Elevated levels of reactive oxygen species in cancer cells promote random lipid peroxidation, which leads to a variety of aldehydes. In the case of lung cancer, many of these volatile aldehydes are exhaled and are of interest as potential markers of the disease. Relevant studies reporting aldehydes in the exhaled breath of lung cancer patients were collected for this review by searching the PubMed and SciFindern databases until 25 May 2022. Information on breath test results, including the biomarker collection, preconcentration, and quantification methods, was extracted and tabulated. Overall, 44 studies were included spanning a period of 34 years. The data show that, as a class, aldehydes are significantly elevated in the breath of lung cancer patients at all stages of the disease relative to healthy control subjects. The type of aldehyde detected and/or deemed to be a biomarker is highly dependent on the method of exhaled breath sampling and analysis. Unsaturated aldehydes, detected primarily when derivatized during preconcentration, are underrepresented as biomarkers given that they are also likely products of lipid peroxidation. Pentanal, hexanal, and heptanal were the most reported aldehydes in studies of exhaled breath from lung cancer patients.


  • Open Access

    Biomarkers of Cardiovascular Toxicity of Benzene Inhalation in Mice

    by Marina V. Malovichko, Wesley T. Abplanalp, Samantha A. McFall, Breandon S. Taylor, Nalinie S. Wickramasinghe, Israel D. Sithu, Igor N. Zelko, Shizuka Uchida, Saurin R. Sutaria, Michael H. Nantz, et al.

    Benzene is a ubiquitous environmental pollutant. Recent population-based studies suggest that benzene exposure is associated with an increased risk for cardiovascular disease. However, it is unclear whether benzene exposure is sufficient to induce cardiovascular toxicity. We examined the effects of benzene inhalation (50 ppm, 6 h/day, 5 days/week, 6 weeks) or HEPA-filtered air exposure on the biomarkers of cardiovascular toxicity in male C57BL/6J mice. Benzene inhalation significantly increased the biomarkers of endothelial activation and injury including endothelial microparticles, activated endothelial microparticles, endothelial progenitor cell microparticles, lung endothelial microparticles, and activated lung and endothelial microparticles while having no effect on circulating levels of endothelial adhesion molecules, endothelial selectins, and biomarkers of angiogenesis. To understand how benzene may induce endothelial injury, we exposed human aortic endothelial cells to benzene metabolites. Of metabolites tested, trans,trans -mucondialdehyde (10 μM, 18h) was most toxic. It induced caspases-3, −7 and −9 (intrinsic pathway) activation, and enhanced microparticle formation by 2.4-fold. Levels of plateletleukocyte aggregates, platelet macroparticles, and proportion of CD4 + and CD8 + T-cells were also significantly elevated in the blood of the benzene-exposed mice. We also found that benzene exposure increased the transcription of genes associated with endothelial cell and platelet activation in the liver; and induced inflammatory genes and suppressed cytochrome P450s in the lungs and the liver. Together, these data suggest that benzene exposure induces endothelial injury, enhances platelet activation and inflammatory processes; and circulatory levels of endothelial cell and platelet-derived microparticles and platelet-leukocyte aggregates are excellent biomarkers of cardiovascular toxicity of benzene. Highlights: Inhaled benzene exposure increases the levels of blood endothelial microparticles. In vitro , benzene metabolite trans, trans -mucondialdehyde induces endothelial cell apoptosis and microparticles formation. Inhaled benzene exposure decreases the levels of hematopoietic progenitor cells in the bone marrow. Inhaled benzene exposure augments the circulating levels of platelet-leukocyte adducts.